Miracle Mile Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.7K | Sell |
5,977
-2,423
| -29% | -$12.8K | ﹤0.01% | 708 |
|
|
2025
Q1 | $37.1K | Hold |
8,400
| – | – | ﹤0.01% | 637 |
|
|
2024
Q4 | $58.8K | Hold |
8,400
| – | – | ﹤0.01% | 624 |
|
|
2024
Q3 | $122K | Hold |
8,400
| – | – | ﹤0.01% | 507 |
|
|
2024
Q2 | $612K | Sell |
8,400
-3,422
| -29% | -$249K | 0.01% | 325 |
|
|
2024
Q1 | $700K | Hold |
11,822
| – | – | 0.02% | 310 |
|
|
2023
Q4 | $865K | Hold |
11,822
| – | – | 0.02% | 280 |
|
|
2023
Q3 | $459K | Hold |
11,822
| – | – | 0.01% | 336 |
|
|
2023
Q2 | $682K | Hold |
11,822
| – | – | 0.02% | 305 |
|
|
2023
Q1 | $768K | Sell |
11,822
-678
| -5% | -$44.1K | 0.02% | 311 |
|
|
2022
Q4 | $344K | Hold |
12,500
| – | – | 0.01% | 408 |
|
|
2022
Q3 | $365K | Hold |
12,500
| – | – | 0.02% | 329 |
|
|
2022
Q2 | $240K | Buy |
+12,500
| New | +$240K | 0.01% | 389 |
|